How big is the cardiopulmonary autotransfusion system market?

While Heart Surgery segment is altered to an CAGR throughout this forecast period.Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028.

Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028

Q: Who are the key players in the cardiopulmonary autotransfusion system market?

Some of the key players are Haemonetics, Medtronic Inc, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, Russia, Others.

Code: QYRE-Auto-17107

Report

January 2022

Pages:92

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Wandong Health Sources

Russia

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

Market Analysis and Insights: Global Cardiopulmonary Autotransfusion System Market

Due to the COVID-19 pandemic, the global Cardiopulmonary Autotransfusion System market size is estimated to be worth US$ 567.4 million in 2022 and is forecast to a readjusted size of US$ 654.2 million by 2028 with a CAGR of 2.4% during the review period.

Fully considering the economic change by this health crisis, Unwashed ATS accounting for % of the Cardiopulmonary Autotransfusion System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Heart Surgery segment is altered to an % CAGR throughout this forecast period.

The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Global Cardiopulmonary Autotransfusion System Scope and Segment

Cardiopulmonary Autotransfusion System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cardiopulmonary Autotransfusion System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Unwashed ATS

Washed ATS

Segment by Application

Heart Surgery

Great Organ Transplant Surgery

Other Surgery

BY COMPANY

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

FEATURED COMPANIES

Wandong Health Sources

Russia

1 Study Coverage

1.1 Cardiopulmonary Autotransfusion System Product Introduction

1.2 Market by Type

1.2.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Unwashed ATS

1.2.3 Washed ATS

1.3 Market by Application

1.3.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Heart Surgery

1.3.3 Great Organ Transplant Surgery

1.3.4 Other Surgery

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Cardiopulmonary Autotransfusion System Sales Estimates and Forecasts 2017-2028

2.2 Global Cardiopulmonary Autotransfusion System Revenue Estimates and Forecasts 2017-2028

2.3 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Cardiopulmonary Autotransfusion System Sales by Region

2.4.1 Global Cardiopulmonary Autotransfusion System Sales by Region (2017-2022)

2.4.2 Global Sales Cardiopulmonary Autotransfusion System by Region (2023-2028)

2.5 Global Cardiopulmonary Autotransfusion System Revenue by Region

2.5.1 Global Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022)

2.5.2 Global Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Cardiopulmonary Autotransfusion System Sales by Manufacturers

3.1.1 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Sales (2017-2022)

3.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cardiopulmonary Autotransfusion System in 2021

3.2 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers

3.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2017-2022)

3.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Cardiopulmonary Autotransfusion System Revenue in 2021

3.3 Global Cardiopulmonary Autotransfusion System Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Cardiopulmonary Autotransfusion System Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Cardiopulmonary Autotransfusion System Sales by Type

4.1.1 Global Cardiopulmonary Autotransfusion System Historical Sales by Type (2017-2022)

4.1.2 Global Cardiopulmonary Autotransfusion System Forecasted Sales by Type (2023-2028)

4.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

4.2 Global Cardiopulmonary Autotransfusion System Revenue by Type

4.2.1 Global Cardiopulmonary Autotransfusion System Historical Revenue by Type (2017-2022)

4.2.2 Global Cardiopulmonary Autotransfusion System Forecasted Revenue by Type (2023-2028)

4.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

4.3 Global Cardiopulmonary Autotransfusion System Price by Type

4.3.1 Global Cardiopulmonary Autotransfusion System Price by Type (2017-2022)

4.3.2 Global Cardiopulmonary Autotransfusion System Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Cardiopulmonary Autotransfusion System Sales by Application

5.1.1 Global Cardiopulmonary Autotransfusion System Historical Sales by Application (2017-2022)

5.1.2 Global Cardiopulmonary Autotransfusion System Forecasted Sales by Application (2023-2028)

5.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

5.2 Global Cardiopulmonary Autotransfusion System Revenue by Application

5.2.1 Global Cardiopulmonary Autotransfusion System Historical Revenue by Application (2017-2022)

5.2.2 Global Cardiopulmonary Autotransfusion System Forecasted Revenue by Application (2023-2028)

5.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

5.3 Global Cardiopulmonary Autotransfusion System Price by Application

5.3.1 Global Cardiopulmonary Autotransfusion System Price by Application (2017-2022)

5.3.2 Global Cardiopulmonary Autotransfusion System Price Forecast by Application (2023-2028)

6 North America

6.1 North America Cardiopulmonary Autotransfusion System Market Size by Type

6.1.1 North America Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)

6.1.2 North America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)

6.2 North America Cardiopulmonary Autotransfusion System Market Size by Application

6.2.1 North America Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)

6.2.2 North America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)

6.3 North America Cardiopulmonary Autotransfusion System Market Size by Country

6.3.1 North America Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)

6.3.2 North America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Cardiopulmonary Autotransfusion System Market Size by Type

7.1.1 Europe Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)

7.1.2 Europe Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)

7.2 Europe Cardiopulmonary Autotransfusion System Market Size by Application

7.2.1 Europe Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)

7.2.2 Europe Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)

7.3 Europe Cardiopulmonary Autotransfusion System Market Size by Country

7.3.1 Europe Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)

7.3.2 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Type

8.1.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)

8.1.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)

8.2 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Application

8.2.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)

8.2.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)

8.3 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Region

8.3.1 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2017-2028)

8.3.2 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Cardiopulmonary Autotransfusion System Market Size by Type

9.1.1 Latin America Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)

9.1.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)

9.2 Latin America Cardiopulmonary Autotransfusion System Market Size by Application

9.2.1 Latin America Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)

9.2.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)

9.3 Latin America Cardiopulmonary Autotransfusion System Market Size by Country

9.3.1 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)

9.3.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Type

10.1.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2017-2028)

10.1.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2017-2028)

10.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Application

10.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2017-2028)

10.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2017-2028)

10.3 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country

10.3.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2017-2028)

10.3.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Haemonetics

11.1.1 Haemonetics Corporation Information

11.1.2 Haemonetics Overview

11.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Haemonetics Recent Developments

11.2 Medtronic

11.2.1 Medtronic Corporation Information

11.2.2 Medtronic Overview

11.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Medtronic Recent Developments

11.3 LivaNova

11.3.1 LivaNova Corporation Information

11.3.2 LivaNova Overview

11.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 LivaNova Recent Developments

11.4 Fresenius Kabi

11.4.1 Fresenius Kabi Corporation Information

11.4.2 Fresenius Kabi Overview

11.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Fresenius Kabi Recent Developments

11.5 Terumo

11.5.1 Terumo Corporation Information

11.5.2 Terumo Overview

11.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Terumo Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Terumo Recent Developments

11.6 Wandong Health Sources

11.6.1 Wandong Health Sources Corporation Information

11.6.2 Wandong Health Sources Overview

11.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Wandong Health Sources Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis

12.2 Cardiopulmonary Autotransfusion System Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Cardiopulmonary Autotransfusion System Production Mode & Process

12.4 Cardiopulmonary Autotransfusion System Sales and Marketing

12.4.1 Cardiopulmonary Autotransfusion System Sales Channels

12.4.2 Cardiopulmonary Autotransfusion System Distributors

12.5 Cardiopulmonary Autotransfusion System Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Cardiopulmonary Autotransfusion System Industry Trends

13.2 Cardiopulmonary Autotransfusion System Market Drivers

13.3 Cardiopulmonary Autotransfusion System Market Challenges

13.4 Cardiopulmonary Autotransfusion System Market Restraints

14 Key Findings in The Global Cardiopulmonary Autotransfusion System Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Wandong Health Sources

Russia

List of Tables

Table 1. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Unwashed ATS

Table 3. Major Manufacturers of Washed ATS

Table 4. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Cardiopulmonary Autotransfusion System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Cardiopulmonary Autotransfusion System Sales by Region (2017-2022) & (Units)

Table 7. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2017-2022)

Table 8. Global Cardiopulmonary Autotransfusion System Sales by Region (2023-2028) & (Units)

Table 9. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2023-2028)

Table 10. Global Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2017-2022)

Table 12. Global Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2023-2028)

Table 14. Global Cardiopulmonary Autotransfusion System Sales by Manufacturers (2017-2022) & (Units)

Table 15. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturers (2017-2022)

Table 16. Global Cardiopulmonary Autotransfusion System Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2017-2022)

Table 18. Cardiopulmonary Autotransfusion System Price by Manufacturers (2017-2022) &(K US$/Unit)

Table 19. Global Cardiopulmonary Autotransfusion System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2021)

Table 21. Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Cardiopulmonary Autotransfusion System Product Offered

Table 23. Date of Manufacturers Enter into Cardiopulmonary Autotransfusion System Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 26. Global Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 27. Global Cardiopulmonary Autotransfusion System Sales Share by Type (2017-2022)

Table 28. Global Cardiopulmonary Autotransfusion System Sales Share by Type (2023-2028)

Table 29. Global Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Cardiopulmonary Autotransfusion System Revenue Share by Type (2017-2022)

Table 32. Global Cardiopulmonary Autotransfusion System Revenue Share by Type (2023-2028)

Table 33. Cardiopulmonary Autotransfusion System Price by Type (2017-2022) & (K US$/Unit)

Table 34. Global Cardiopulmonary Autotransfusion System Price Forecast by Type (2023-2028) & (K US$/Unit)

Table 35. Global Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 36. Global Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 37. Global Cardiopulmonary Autotransfusion System Sales Share by Application (2017-2022)

Table 38. Global Cardiopulmonary Autotransfusion System Sales Share by Application (2023-2028)

Table 39. Global Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Cardiopulmonary Autotransfusion System Revenue Share by Application (2017-2022)

Table 42. Global Cardiopulmonary Autotransfusion System Revenue Share by Application (2023-2028)

Table 43. Cardiopulmonary Autotransfusion System Price by Application (2017-2022) & (K US$/Unit)

Table 44. Global Cardiopulmonary Autotransfusion System Price Forecast by Application (2023-2028) & (K US$/Unit)

Table 45. North America Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 46. North America Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 47. North America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 50. North America Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 51. North America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)

Table 54. North America Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)

Table 55. North America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 58. Europe Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 59. Europe Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 62. Europe Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 63. Europe Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)

Table 66. Europe Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)

Table 67. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 70. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 71. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 74. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 75. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2017-2022) & (Units)

Table 78. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2023-2028) & (Units)

Table 79. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 82. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 83. Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 86. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 87. Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)

Table 90. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)

Table 91. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2017-2022) & (Units)

Table 94. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2023-2028) & (Units)

Table 95. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2017-2022) & (Units)

Table 98. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2023-2028) & (Units)

Table 99. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2017-2022) & (Units)

Table 102. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2023-2028) & (Units)

Table 103. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2023-2028) & (US$ Million)

Table 105. Haemonetics Corporation Information

Table 106. Haemonetics Description and Major Businesses

Table 107. Haemonetics Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 108. Haemonetics Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Haemonetics Recent Developments

Table 110. Medtronic Corporation Information

Table 111. Medtronic Description and Major Businesses

Table 112. Medtronic Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 113. Medtronic Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Medtronic Recent Developments

Table 115. LivaNova Corporation Information

Table 116. LivaNova Description and Major Businesses

Table 117. LivaNova Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 118. LivaNova Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. LivaNova Recent Developments

Table 120. Fresenius Kabi Corporation Information

Table 121. Fresenius Kabi Description and Major Businesses

Table 122. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 123. Fresenius Kabi Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Fresenius Kabi Recent Developments

Table 125. Terumo Corporation Information

Table 126. Terumo Description and Major Businesses

Table 127. Terumo Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 128. Terumo Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Terumo Recent Developments

Table 130. Wandong Health Sources Corporation Information

Table 131. Wandong Health Sources Description and Major Businesses

Table 132. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2017-2022)

Table 133. Wandong Health Sources Cardiopulmonary Autotransfusion System Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Wandong Health Sources Recent Developments

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Cardiopulmonary Autotransfusion System Distributors List

Table 138. Cardiopulmonary Autotransfusion System Customers List

Table 139. Cardiopulmonary Autotransfusion System Market Trends

Table 140. Cardiopulmonary Autotransfusion System Market Drivers

Table 141. Cardiopulmonary Autotransfusion System Market Challenges

Table 142. Cardiopulmonary Autotransfusion System Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Cardiopulmonary Autotransfusion System Product Picture

Figure 3. Global Cardiopulmonary Autotransfusion System Market Share by Type in 2021 & 2028

Figure 3. Unwashed ATS Product Picture

Figure 4. Washed ATS Product Picture

Figure 5. Global Cardiopulmonary Autotransfusion System Market Share by Application in 2021 & 2028

Figure 6. Heart Surgery

Figure 7. Great Organ Transplant Surgery

Figure 8. Other Surgery

Figure 9. Cardiopulmonary Autotransfusion System Report Years Considered

Figure 10. Global Cardiopulmonary Autotransfusion System Sales 2017-2028 (Units)

Figure 11. Global Cardiopulmonary Autotransfusion System Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Cardiopulmonary Autotransfusion System Revenue 2017-2028 (US$ Million)

Figure 13. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2017-2022)

Figure 15. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2023-2028)

Figure 16. North America Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)

Figure 17. North America Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)

Figure 19. Europe Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)

Figure 21. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)

Figure 23. Latin America Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Cardiopulmonary Autotransfusion System Sales YoY (2017-2028) & (Units)

Figure 25. Middle East & Africa Cardiopulmonary Autotransfusion System Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Cardiopulmonary Autotransfusion System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Cardiopulmonary Autotransfusion System in the World: Market Share by Cardiopulmonary Autotransfusion System Revenue in 2021

Figure 28. Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 30. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 31. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 32. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 33. North America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 34. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 35. North America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 36. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 37. North America Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)

Figure 38. North America Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)

Figure 39. U.S. Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 42. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 43. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 44. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 45. Europe Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)

Figure 46. Europe Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)

Figure 47. Germany Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 48. France Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Cardiopulmonary Autotransfusion System Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Share by Region (2017-2028)

Figure 58. China Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 61. India Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 63. China Taiwan Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 67. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 68. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 69. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 70. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 71. Latin America Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)

Figure 72. Latin America Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)

Figure 73. Mexico Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 74. Brazil Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 75. Argentina Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 76. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Share by Country (2017-2028)

Figure 81. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Share by Country (2017-2028)

Figure 82. Turkey Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 83. Saudi Arabia Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 84. UAE Cardiopulmonary Autotransfusion System Revenue (2017-2028) & (US$ Million)

Figure 85. Cardiopulmonary Autotransfusion System Value Chain

Figure 86. Cardiopulmonary Autotransfusion System Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-17107

Global Cardiopulmonary Autotransfusion System Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29U9219

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G9187

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10A6252

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-36N6053

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions